Target
amyloid beta
3 abstracts
Abstract
WITHDRAWN: A phase 0/1b study of AZD1390 plus radiotherapy in patients with recurrent glioblastoma.Org: Barrow Neurological Institute, Ivy Brain Tumor Center,
Abstract
WITHDRAWN: A phase II study analyzing pre-operative stereotactic radiosurgery followed by resection for patients with 1-4 brain metastases.Org: Simon Cancer Center, Indianapolis, IN, Department of Radiation Oncology, Indiana University School of Medicine, Department of Clinical Radiology and Imaging Sciences,
Abstract
Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).Org: IRCCS Foundation National Cancer Institute, Milan, Italy, Molinette Hospital, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Fondazione Policlinico Campus Bio-Medico, Orthopaedic Institute Rizzoli,